Calypso Raises Series D

Calypso Medical Technologies Inc., a Seattle-based developer of medical devices for cancer therapy, has raised $42.2 million in Series D funding. Apothecary Capital, Glenview Capital Management and Pequot Capital were joined by return backers Versant Ventures, Integra Ventures, Frazier Healthcare Ventures, Kaiser Permanente Ventures, Merlin BioMed Group, RiverVest Venture Partners and UV Ventures. Calypso has raised around $123 million in total VC funding since its 1999 inception.